Swor Care
- Laser Therapy (LLLT)
- Arthritis Treatment
- Hormone Replacement Therapy (HRT)
- Stem Cell Therapy
Sarasota, FL
Stem cell offers in Sarasota mix orthopedic and regenerative marketing along University Parkway suites with cash-pay longevity menus nearer downtown Main Street and Pineapple Avenue. Siesta Key ads often sell the same three words with thinner consent packets. Lakewood Ranch and Bradenton are drive time, not this hub.
"Stem cell" on a Gulf Coast menu can mean very different products, sites of care, and evidence grades. Ask what is actually injected or infused, who harvests or sources it, and what outcomes are tracked in writing.
This hub lists Directory clinics for Sarasota and stem cell therapy. Inclusion is not an endorsement. Listing order is not paid ranking. Regenerated.com is free for patients. Featured slots stay labeled; Verified means credential checks, not spend.
Ask for the exact product name, FDA regulatory status in plain language, imaging or exam criteria before treatment, and how adverse events are handled. Prefer plain risk talk. Use the national stem cell Directory and Guide, then return here.
Before you trust badges or counts on this page, read How to read a Regenerated city hub and Featured vs Verified vs organic. Then return here for local listings.
Regulatory context
Florida cellular therapy providers are governed by 21 CFR Part 1271. Section 361 applies to minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 applies to products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND or BLA. Most stem cell, stromal vascular fraction, exosome, umbilical cord blood derived, and culture-expanded mesenchymal cell therapies marketed in Florida for orthopedic, neurologic, autoimmune, and longevity indications fall under Section 351 and lack FDA approval. Florida is a high-volume market, which has translated into elevated federal scrutiny.
Florida has been a primary target of FDA enforcement. In US v US Stem Cell Inc (2019), a federal court in Florida granted a permanent injunction against a Sunrise-based clinic for marketing unapproved stem cell products derived from adipose tissue. The Eleventh Circuit upheld the injunction in 2021. The FDA has issued multiple warning letters to Florida clinics offering exosome and umbilical cord-derived therapies. The Florida Department of Health and the Boards of Medicine and Osteopathic Medicine have disciplined physicians for unprofessional conduct tied to misleading regenerative medicine marketing. The Florida Attorney General has pursued deceptive trade practice claims under FDUTPA against stem cell clinics.
Available here
Nationwide
Stem Cell Therapy clinics across the US